Zobrazeno 1 - 10
of 308
pro vyhledávání: '"L. Mammen"'
Autor:
Christopher A. Mecoli, David Fiorentino, Jemima Albayda, Julie J. Paik, Eleni Tiniakou, Brittany Adler, Andrew L. Mammen, Lisa Christopher‐Stine, Antony Rosen, Livia Casciola‐Rosen
Publikováno v:
ACR Open Rheumatology, Vol 6, Iss 12, Pp 912-917 (2024)
Objective The objective of this study was to describe the frequency, co‐occurrence, and cancer association of anti–cell division cycle and apoptosis regulator 1 (anti‐CCAR1) and anti‐Sp4 in two large independent adult dermatomyositis (DM) coh
Externí odkaz:
https://doaj.org/article/d8cf74ff106f4d69bee65750100e682b
Autor:
Peter D. Burbelo, Julio A. Huapaya, Zohreh Khavandgar, Margaret Beach, Iago Pinal-Fernandez, Andrew L. Mammen, John A. Chiorini, Payam Noroozi Farhadi, Frederick W. Miller, Adam Schiffenbauer, Kakali Sarkar, Blake M. Warner, Lisa G. Rider
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Autoantibodies are important for the diagnosis of autoimmune interstitial lung disease (ILD). Standard immunoassays have limitations, including their qualitative nature and/or a narrow dynamic range of detection, hindering the usefulness of autoantib
Externí odkaz:
https://doaj.org/article/64b96c4ac6b14506921ee64e276ed00b
Autor:
Sandra Donkervoort, Payam Mohassel, Melanie O'Leary, Devon E. Bonner, Taila Hartley, Nicole Acquaye, Astrid Brull, Tahseen Mozaffar, Mario A. Saporta, David A. Dyment, Jacinda B. Sampson, Sander Pajusalu, Christina Austin‐Tse, Kyle Hurth, Julie S. Cohen, Kirsty McWalter, Jodi Warman‐Chardon, Amy Crunk, A. Reghan Foley, Undiagnosed Diseases Network, Andrew L. Mammen, Matthew T. Wheeler, Anne O'Donnell‐Luria, Carsten G. Bönnemann
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 11, Iss 3, Pp 629-640 (2024)
Abstract Objective ACTN2, encoding alpha‐actinin‐2, is essential for cardiac and skeletal muscle sarcomeric function. ACTN2 variants are a known cause of cardiomyopathy without skeletal muscle involvement. Recently, specific dominant monoallelic
Externí odkaz:
https://doaj.org/article/fb0a803a096f45d484f086ba7b3ad84b
Autor:
Brian Walitt, Komudi Singh, Samuel R. LaMunion, Mark Hallett, Steve Jacobson, Kong Chen, Yoshimi Enose-Akahata, Richard Apps, Jennifer J. Barb, Patrick Bedard, Robert J. Brychta, Ashura Williams Buckley, Peter D. Burbelo, Brice Calco, Brianna Cathay, Li Chen, Snigdha Chigurupati, Jinguo Chen, Foo Cheung, Lisa M. K. Chin, Benjamin W. Coleman, Amber B. Courville, Madeleine S. Deming, Bart Drinkard, Li Rebekah Feng, Luigi Ferrucci, Scott A. Gabel, Angelique Gavin, David S. Goldstein, Shahin Hassanzadeh, Sean C. Horan, Silvina G. Horovitz, Kory R. Johnson, Anita Jones Govan, Kristine M. Knutson, Joy D. Kreskow, Mark Levin, Jonathan J. Lyons, Nicholas Madian, Nasir Malik, Andrew L. Mammen, John A. McCulloch, Patrick M. McGurrin, Joshua D. Milner, Ruin Moaddel, Geoffrey A. Mueller, Amrita Mukherjee, Sandra Muñoz-Braceras, Gina Norato, Katherine Pak, Iago Pinal-Fernandez, Traian Popa, Lauren B. Reoma, Michael N. Sack, Farinaz Safavi, Leorey N. Saligan, Brian A. Sellers, Stephen Sinclair, Bryan Smith, Joseph Snow, Stacey Solin, Barbara J. Stussman, Giorgio Trinchieri, Sara A. Turner, C. Stephenie Vetter, Felipe Vial, Carlotta Vizioli, Ashley Williams, Shanna B. Yang, Center for Human Immunology, Autoimmunity, and Inflammation (CHI) Consortium, Avindra Nath
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-29 (2024)
Abstract Post-infectious myalgic encephalomyelitis/chronic fatigue syndrome (PI-ME/CFS) is a disabling disorder, yet the clinical phenotype is poorly defined, the pathophysiology is unknown, and no disease-modifying treatments are available. We used
Externí odkaz:
https://doaj.org/article/a14b918b7de649e6975c4ac14fdd7aa8
Autor:
Maria Casal-Dominguez, Iago Pinal-Fernandez, Katherine Pak, Sandra Muñoz-Braceras, Jose C. Milisenda, Jiram Torres-Ruiz, Stefania Dell′Orso, Faiza Naz, Gustavo Gutierrez-Cruz, Yaiza Duque-Jaimez, Ana Matas-Garcia, Laura Valls-Roca, Gloria Garrabou, Ernesto Trallero-Araguas, Brian Walitt, Lisa Christopher-Stine, Thomas E. Lloyd, Julie J. Paik, Jemima Albayda, Andrea Corse, Josep Maria Grau, Albert Selva-O’Callaghan, Andrew L. Mammen
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Complement proteins are deposited in the muscles of patients with myositis. However, the local expression and regulation of complement genes within myositis muscle have not been well characterized. In this study, bulk RNA sequencing (RNAseq)
Externí odkaz:
https://doaj.org/article/432560f2a1924ebb82edb93b6abbedca
Autor:
Yuriy Baglaenko, Catriona Wagner, Vijay G. Bhoj, Petter Brodin, M. Eric Gershwin, Daniel Graham, Pietro Invernizzi, Kenneth K. Kidd, Ilya Korsunsky, Michael Levy, Andrew L. Mammen, Victor Nizet, Francisco Ramirez-Valle, Edward C. Stites, Marc S. Williams, Michael Wilson, Noel R. Rose, Virginia Ladd, Marina Sirota
Publikováno v:
Cambridge Prisms: Precision Medicine, Vol 1 (2023)
Precision Medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle. Autoimmune diseases are those in which the body’s natural defense system loses disc
Externí odkaz:
https://doaj.org/article/bcf797b4c46e41e2bed7e76f1a48f825
Autor:
Sandra Muñoz-Braceras, Iago Pinal-Fernandez, Maria Casal-Dominguez, Katherine Pak, José César Milisenda, Shajia Lu, Massimo Gadina, Faiza Naz, Gustavo Gutierrez-Cruz, Stefania Dell’Orso, Jiram Torres-Ruiz, Josep Maria Grau-Junyent, Albert Selva-O’Callaghan, Julie J. Paik, Jemima Albayda, Lisa Christopher-Stine, Thomas E. Lloyd, Andrea M. Corse, Andrew L. Mammen
Publikováno v:
Cells, Vol 12, Iss 17, p 2198 (2023)
Dermatomyositis (DM), antisynthetase syndrome (AS), immune-mediated necrotizing myopathy (IMNM), and inclusion body myositis (IBM) are four major types of idiopathic inflammatory myopathy (IIM). Muscle biopsies from each type of IIM have unique trans
Externí odkaz:
https://doaj.org/article/430bca4e170c4fd7ba24d5229acce44e
Autor:
Jemima Albayda, Christopher Mecoli, Livia Casciola‐Rosen, Sonye K. Danoff, Cheng Ting Lin, David Hines, Laura Gutierrez‐Alamillo, Julie J. Paik, Eleni Tiniakou, Andrew L. Mammen, Lisa Christopher‐Stine
Publikováno v:
ACR Open Rheumatology, Vol 3, Iss 5, Pp 287-294 (2021)
Objective Antibodies against the small ubiquitin‐like modifier (SUMO) activating enzyme (SAE) are one of the rarer specificities associated with dermatomyositis (DM). The purpose of this study is to describe the clinical characteristics of patients
Externí odkaz:
https://doaj.org/article/e28a870f7a4545ddbb39a9127d21547e
Autor:
Andrew L Mammen, Anthony A Amato, Mazen M Dimachkie, Hector Chinoy, Yessar Hussain, James B Lilleker, Iago Pinal-Fernandez, Yves Allenbach, Babak Boroojerdi, Mark Vanderkelen, Eumorphia Maria Delicha, Harold Koendgen, Ramin Farzaneh-Far, Petra W Duda, Camil Sayegh, Olivier Benveniste, Anthony A. Amato, Suur Biliciler, Mazen M. Dimachkie, Christyn Edmundson, Miriam Freimer, Anthony Geraci, Pedro Machado, Andrew L. Mammen, Tahseen Mozaffar, Payam Soltanzadeh, Niraja Suresh, Anneke van der Kooi, Matthew Appleby, Richard J Barohn, Nicolas Champtiaux, Christopher Doughty, Jerrica Farias, Constantine Farmakidis, Ali A. Habib, Chafic Karam, James Lilleker, Samantha Lorusso, Mamatha Pasnoor, Giorgia Querin, Joost Raaphorst, George Ransley, Sami Saba, Kazim Sheikh, Andrew Snedden, Jeffrey Statland, Tuan Vu
Publikováno v:
The Lancet Rheumatology, 5(2), e67-e76. Lancet Publishing Group
Background: Immune-mediated necrotising myopathy is an autoimmune myopathy characterised by proximal muscle weakness, high creatine kinase concentrations, and autoantibodies recognising 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) or the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::226dfb286f8e7e3dd1c850014b828f66
https://doi.org/10.1016/s2665-9913(23)00003-6
https://doi.org/10.1016/s2665-9913(23)00003-6
Autor:
Andrew L Mammen, Jarushka Naidoo, Divyanshu Dubey, Michael Dougan, Teilo H Schaller, Meghan J Mooradian, Douglas B Johnson, Jorg Dietrich, Leyre Zubiri, Tomas G Neilan, Bianca D Santomasso, Allison Betof Warner, Justine V Cohen, Nancy Wang, Jenny Linnoila, Jeffrey M Gelfand, Anthony A Amato, Stacey L Clardy, David A Reardon, William C Louv, Amanda C Guidon, Leeann B Burton, Bart K Chwalisz, James Hillis, Priscilla K Brastianos, Tracey A Cho, Christopher T Doughty, Jeffrey T Guptill, Vern C Juel, Robert Kadish, Noah Kolb, Nicole R LeBoeuf, Maria Martinez-Lage, Krista M Rubin, Karin Woodman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Expanding the US Food and Drug Administration–approved indications for immune checkpoint inhibitors in patients with cancer has resulted in therapeutic success and immune-related adverse events (irAEs). Neurologic irAEs (irAE-Ns) have an incidence
Externí odkaz:
https://doaj.org/article/a2206707f599451b8603379684ad2015